We can’t show the full text here under this license.
How plants produce psychedelic tryptamines using complete natural pathways from three life groups
Updated
Abstract
Essence
The paper rebuilds DMT-related psychedelic biosynthesis in plants as a production and diversification platform.
Evidence
A plant metabolic-engineering platform experiment reconstructed pathways for psilocin, psilocybin, DMT, bufotenin, 5-methoxy-DMT, and halogenated analogs.
Caveat
The abstract reports biosynthesis and enzyme-engineering performance, not therapeutic activity, safety, or clinical usefulness of the products.
Simplified